Eris Lifesciences

Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and a leading player in the domestic branded formulations market. The company is strategically evolving from an "India-only" business to an "India + RoW Exports" business, aiming for a more geographically diverse operation. Its approach is centered on providing science-led and outcome-driven healthcare, with a primary focus on specialty and super-specialty medical treatments. Its main product areas include therapies for Oral Anti-Diabetes, Cardiovascular diseases, Vitamins, Dermatology, Insulins, Women's Health, Critical Care, and Oncology. Through acquisitions, it has expanded its portfolio to enter the Nephrology, Psoriasis, Oncology, and Critical Care spaces, strengthening its super-specialty presence. This strong focus is reflected in its brand portfolio, where the top 25 mother brands contribute to 63% of its domestic branded formulations revenue.;